Some drugs that have therapeutic benefits are banned because of emerging patterns of use that do not conform to dominant paradigms. Such policies are often driven by morality rather than evidence.
This presentation was delivered by PRISM Vice President Stephen Bright PhD at the 2013 APSAD Scientific Alcohol and Drug Conference in Brisbane. You can listen to the recorded presentation below and download the presentation slides here.
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
